Review of Breast Conservation Therapy: then and Now

Overview

Journal ISRN Oncol

Specialty Oncology

Date 2012 Jan 10

PMID 22229101

Citations 8

Authors

Susan Hoover

Elizabeth Bloom

Sunil Patel

Affiliations

Soon will be listed here.

Abstract

Breast conservation therapy (BCT), which is the marriage of breast conserving surgery and radiation therapy to the breast, has revolutionized the treatment of breast cancer over the last few decades. Surgical direction had seen a heightened interest in the performance of cosmetically superior partial and segmental resections in breast conservation as well as increased demand by patients for breast preservation. The broadening of approaches to delivery of breast irradiation from whole breast to accelerated partial breast has allowed more patients to opt for breast conservation and allowed for what appears to be comparable measurable outcomes in emerging data. As well, the addition of state-of-the-art chemotherapeutic and hormonal therapies has allowed improved outcomes of patients from both local regional recurrence and overall survival standpoints. This paper will provide an overview of BCT and review some of the newest developments in optimizing this therapy for patients with breast cancer from a surgical-, medical-, and radiation-oncology standpoint.

Citing Articles

Global prevalence and factors associated with preoperative depression in women undergoing breast surgery: a meta-analysis and meta-regression.

Leo C, Cheng L, Lam X, He H Breast Cancer Res Treat. 2024; 205(3):425-438.

PMID: 38492162 DOI: 10.1007/s10549-023-07216-3.

Therapeutic mammoplasty: a "wise" oncoplastic choice-lessons from the largest single-center cohort from Asia.

Koppiker C, Joshi S, Mishra R, Kelkar D, Chigurupati P, Joshi A Front Oncol. 2023; 13:1131951.

PMID: 37124516 PMC: 10141318. DOI: 10.3389/fonc.2023.1131951.

Image-Guided Breast Interventions: Biopsy and Beyond.

Dhamija E, Singh R, Mishra S, Hari S Indian J Radiol Imaging. 2021; 31(2):391-399.

PMID: 34556924 PMC: 8448213. DOI: 10.1055/s-0041-1734223.

The Importance of Alexithymia in Post-surgery. Differences on Body Image and Psychological Adjustment in Breast Cancer Patients.

Gutierrez Hermoso L, Velasco Furlong L, Sanchez-Roman S, Salas Costumero L Front Psychol. 2021; 11:604004.

PMID: 33391123 PMC: 7775299. DOI: 10.3389/fpsyg.2020.604004.

Trends of mastectomy and breast-conserving surgery and related factors in female breast cancer patients treated at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, 2009-2017: A retrospective cohort study.

Al-Gaithy Z, Yaghmoor B, Koumu M, Alshehri K, Saqah A, Alshehri H Ann Med Surg (Lond). 2019; 41:47-52.

PMID: 31245000 PMC: 6582239. DOI: 10.1016/j.amsu.2019.03.012.

References

Ellis M, Tao Y, Luo J, AHern R, Evans D, Bhatnagar A . Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst. 2008; 100(19):1380-8. PMC: 2556704. DOI: 10.1093/jnci/djn309. View

Vicini F, Antonucci J, Wallace M, Gilbert S, Goldstein N, Kestin L . Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys. 2007; 68(2):341-6. DOI: 10.1016/j.ijrobp.2006.12.007. View

Sioshansi S, Rivard M, Hiatt J, Hurley A, Lee Y, Wazer D . Dose modeling of noninvasive image-guided breast brachytherapy in comparison to electron beam boost and three-dimensional conformal accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010; 80(2):410-6. DOI: 10.1016/j.ijrobp.2010.01.052. View

van Nes J, Putter H, Julien J, Tubiana-Hulin M, Van de Vijver M, Bogaerts J . Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902. Breast Cancer Res Treat. 2008; 115(1):101-13. DOI: 10.1007/s10549-008-0050-1. View

Katz A, Saad E, Porter P, Pusztai L . Primary systemic chemotherapy of invasive lobular carcinoma of the breast. Lancet Oncol. 2007; 8(1):55-62. DOI: 10.1016/S1470-2045(06)71011-7. View

Buchholz T . Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med. 2009; 360(1):63-70. DOI: 10.1056/NEJMct0803525. View

Robinson G, Van Heerden J, Payne W, Taylor W, Gaffey T . The primary surgical treatment of carcinoma of the breast: a changing trend toward modified radical mastectomy. Mayo Clin Proc. 1976; 51(7):433-42. View

Rastogi P, Anderson S, Bear H, Geyer C, Kahlenberg M, Robidoux A . Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008; 26(5):778-85. DOI: 10.1200/JCO.2007.15.0235. View

Dickler A, Kirk M, Choo J, Hsi W, Chu J, Dowlatshahi K . Treatment volume and dose optimization of MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2004; 59(2):469-74. DOI: 10.1016/j.ijrobp.2003.10.046. View

10.

Song H, Styblo T, Carlson G, Losken A . The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ. Breast J. 2010; 16(2):141-6. DOI: 10.1111/j.1524-4741.2009.00891.x. View

11.

Sarrazin D, Le M, Arriagada R, Contesso G, Fontaine F, Spielmann M . Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989; 14(3):177-84. DOI: 10.1016/0167-8140(89)90165-5. View

12.

Keating N, Weeks J, Borbas C, Guadagnoli E . Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed?. Breast Cancer Res Treat. 2003; 79(2):225-31. DOI: 10.1023/a:1023903701674. View

13.

Shaitelman S, Kim L, Yan D, Martinez A, Vicini F, Grills I . Continuous arc rotation of the couch therapy for the delivery of accelerated partial breast irradiation: a treatment planning analysis. Int J Radiat Oncol Biol Phys. 2010; 80(3):771-8. DOI: 10.1016/j.ijrobp.2010.03.004. View

14.

Lazovich D, Solomon C, Thomas D, Moe R, White E . Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999; 86(4):628-37. View

15.

Wang H, Barone C, Steigelman M, Kahlenberg M, Rousseau D, Berger J . Aesthetic outcomes in breast conservation therapy. Aesthet Surg J. 2008; 28(2):165-70. DOI: 10.1016/j.asj.2007.12.001. View

16.

van Dongen J, Bartelink H, Fentiman I, Lerut T, Mignolet F, Olthuis G . Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer. 1992; 28A(4-5):801-5. DOI: 10.1016/0959-8049(92)90118-l. View

17.

Ashikaga T, Krag D, Land S, Julian T, Anderson S, Brown A . Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010; 102(2):111-8. PMC: 3072246. DOI: 10.1002/jso.21535. View

18.

Edmundson G, Vicini F, Chen P, Mitchell C, Martinez A . Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2002; 52(4):1132-9. DOI: 10.1016/s0360-3016(01)02773-0. View

19.

Sorlie T, Tibshirani R, Parker J, Hastie T, Marron J, Nobel A . Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003; 100(14):8418-23. PMC: 166244. DOI: 10.1073/pnas.0932692100. View

20.

Katz S, Lantz P, Janz N, Fagerlin A, Schwartz K, Liu L . Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol. 2005; 23(24):5526-33. DOI: 10.1200/JCO.2005.06.217. View